News Focus
News Focus
icon url

Rdunn88

05/09/18 8:18 AM

#227320 RE: 58nout #227315

Not true, the FDA has to first clear OM before any alliance. Shame Leo mentioned nothing of this today. The wait continues as 2018 goes by the waste side.
icon url

frrol

05/09/18 8:47 AM

#227335 RE: 58nout #227315

I wonder if this "data analysis conclusion" held up the FDA data submission and meeting, and its BTD verdict. (I think the clock starts upon submission: 60 days for BTD decision.) Company doesn't say here. We do know from March that the company was still "preparing for an FDA meeting", pulling together the CSR and a briefing package.

http://www.ipharminc.com/press-release/2018/3/15/innovation-pharmaceuticals-views-brilacidin-om-as-clearly-differentiated-compared-to-limited-competition-for-preventing-severe-oral-mucositis

Anyway, a nice B-OM update from the company.
icon url

Pipilongstocking

05/09/18 8:49 AM

#227338 RE: 58nout #227315

I like the word cementing.
icon url

Pipilongstocking

05/09/18 8:51 AM

#227340 RE: 58nout #227315

And I like “all of our”. Maybe I am just glass half full but I like his word choices.
icon url

petemantx

05/09/18 9:59 AM

#227364 RE: 58nout #227315

Did they spell "specialty pharmaceutical companies" correctly? I thought the correct spelling was EVONIK?

Already operating in 38 countries, 38,000 employees, ability to mfr every possible type of drug formulation, strong financial position - seems like an Evonik/IPIX hookup would be a mighty strong partnership.